Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episode.

[1]  J. Gisbert,et al.  Systematic review: hepatitis‐associated aplastic anaemia – a syndrome associated with abnormal immunological function , 2009, Alimentary pharmacology & therapeutics.

[2]  N. Young,et al.  Aplastic anemia , 2008, Current opinion in hematology.

[3]  Y. Dror,et al.  Outcome of children with aplastic anemia treated with immunosuppressive therapy , 2008, Pediatric blood & cancer.

[4]  E. Takeshita,et al.  Recurrence of hepatitis-associated aplastic anemia after a 10-year interval. , 2008, Internal medicine.

[5]  Allen R. Chen,et al.  Treatment of hepatitis‐associated aplastic anemia with high‐dose cyclophosphamide , 2006, Pediatric blood & cancer.

[6]  Masuji Yamamoto,et al.  Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia , 2007, Haematologica.

[7]  Brian D. Poole,et al.  Parvovirus B19-Induced Apoptosis of Hepatocytes , 2004, Journal of Virology.

[8]  N. Young,et al.  Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. , 2004, Blood.

[9]  A. Nagler,et al.  Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation , 2001, Bone Marrow Transplantation.

[10]  M. Guiguet,et al.  Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. , 1990, Blood.

[11]  N. Young,et al.  APLASTIC ANAEMIA IN THE ORIENT , 1986, British journal of haematology.

[12]  L. Hagler,et al.  Aplastic anemia following viral hepatitis: report of two fatal cases and literature review. , 1975, Medicine.